Skip to Content

Join the 'Ovarian Cancer' group to help and get support from people like you.

Ovarian Cancer News

Related terms: Cancer, Ovarian, Cancer, Ovaries

'One-Stop' Blood Test for Cancer Shows Early Promise

Posted 5 days ago by Drugs.com

THURSDAY, Jan. 18, 2018 – In an early step toward "one-stop" screening for cancer, researchers report they've developed a blood test that can detect eight types of the disease. The blood test is dubbed CancerSEEK. It was able to catch cancer cases anywhere from 33 percent to 98 percent of the time, depending on the type. The accuracy range was better – 69 percent to 98 percent – when it came to five cancers that currently have no widely used screening test, the scientists reported in a new study. Those cancers included ovarian, pancreatic, stomach, liver and esophageal cancers. The researchers said the findings are an "exciting" initial step. The hope is to eventually have a single blood test that can screen people for a range of common cancers. "This is a proof-of-concept," said Dr. Anne Marie Lennon, one of the researchers on the work. "Will this eventually impact patients' care? I ... Read more

Related support groups: Cancer, Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Head and Neck Cancer, Gastric Cancer, Diagnosis and Investigation

The Pill Lowers Ovarian Cancer Risk, Even for Smokers

Posted 6 days ago by Drugs.com

THURSDAY, Jan. 18, 2018 – It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese. According to the study from the U.S. National Cancer Institute, these trends were also observed for endometrial cancer as well. Long-term use of the pill was linked to reductions in risk for both cancers, and this was "generally consistent across health behaviors," according to a team led by Kara Michels, a cancer institute epidemiologist. The researchers looked at data from a U.S. study that tracked the health of women from 1995 to 2011. At least 100,000 of the women said they were using an oral contraceptive at the beginning of the study. Michels' group found a 40 percent reduction in the risk of ovarian cancer for women who used the pill for 10 years or more. Furthermore, that benefit was ... Read more

Related support groups: Birth Control, Contraception, Plan B, Depo-Provera, Nexplanon, Mirena, NuvaRing, Provera, Sprintec, Implanon, Ortho Tri-Cyclen, Microgestin Fe 1/20, Tri-Sprintec, Yasmin, Plan B One-Step, Loestrin 24 Fe, Ortho Evra, TriNessa, Mononessa, Lutera

New Trial Cancer Drug, Ulixertinib, Shows Promise Against Wide Range of Tumors

Posted 15 Dec 2017 by Drugs.com

FRIDAY, Dec. 15, 2017 – A new drug that targets a genetic flaw common to most cancer cells is showing potency against many tumor types. The preliminary trial of a drug called ulixertinib was conducted with 135 patients who had already failed treatments for one of a variety of advanced, solid tumors. Researchers led by Dr. Ryan Sullivan, of Massachusetts General Hospital, said ulixertinib did seem to spur at least a "partial response" to the therapy or "disease stabilization," regardless of cancer type. "It was exciting to see responses in some patients," said Sullivan, an oncologist and member of the Termeer Center for Targeted Therapies at the Boston hospital. "The results of this study can be built upon to develop better treatment regimens for these patients," he said in a news release from the American Association for Cancer Research (AACR). One cancer specialist explained how ... Read more

Related support groups: Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Ovarian Cancer, Solid Tumors

Memo to Doctors: Spit Out the Bad News

Posted 27 Nov 2017 by Drugs.com

MONDAY, Nov. 27, 2017 – Doctors, don't be afraid to deliver bad news. Telling cancer patients the truth about their chances of survival does not harm a physician's relationship with those people. It could even make it better, according to a new study. "We hope this information will reassure clinicians about any negative impacts of these discussions on their relationships with patients," said study lead author Joshua Fenton. "Discussing prognosis doesn't undermine trust – and informing patients may have large benefits in terms of future quality of life," added Fenton. He is a professor of family and community medicine at the University of California, Davis. The study included 238 adults with advanced cancer. The patients received bad news about their disease progression from oncologists in New York state and California. Interviews with the patients showed that hearing the poor ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Cervical Cancer, Breast Cancer - Palliative

Know the Signs of Ovarian Cancer and Your Risks

Posted 10 Nov 2017 by Drugs.com

THURSDAY, Nov. 9, 2017 – About 22,440 American women will learn they have ovarian cancer this year, and more than 14,000 will die from the disease, according to the American Cancer Society. Often called a "silent killer," ovarian cancer is the 9th most common type of malignancy in women in the United States. Every woman should know the risks and symptoms of ovarian cancer. While the causes are unclear, those at increased risk are over age 55; those with a close relative (mother, daughter or sister) with ovarian cancer; and women with a family history of breast, uterine or colon cancers, according to the Valley Health System in Ridgewood, N.J. Others at increased risk include women who have had breast, uterine or colon cancer and women who have never been pregnant. Women with a strong family history of ovarian or breast cancer may be candidates for genetic testing to check for a ... Read more

Related support groups: Cancer, Breast Cancer, Menstrual Disorders, Premenstrual Dysphoric Disorder, Premenstrual Syndrome, Period Pain, Ovarian Cancer, Menorrhagia, Dysmenorrhea

Health Tip: Being a Cancer Caregiver

Posted 27 Oct 2017 by Drugs.com

-- Helping to care for a person with cancer may involve issues ranging from understanding medication side effects and communicating with family to providing information to a patient's doctor to help determine if a treatment is working. The American Cancer Society offers this advice for cancer caregivers, recognizing they may feel overworked and under-appreciated: Always respect your feelings and those of the patient. Use "I" statements, rather than "you" statements. For instance, say, "I need a break" instead of "You never help me!" Focus on the present rather than bringing up past patterns or issues. Offer comforting assertions, such as: "I want to be here for you to help you get through this. You're not alone." Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer, Breast Cancer - Palliative

What You May Not Know About Ovarian Cancer

Posted 24 Oct 2017 by Drugs.com

TUESDAY, Oct. 24, 2017 – In a report that will likely surprise many women, researchers say most cases of ovarian cancer originate in the fallopian tubes, not the ovaries. "Based on a better understanding of its origins, our study suggests new strategies for the prevention and early detection of ovarian cancer," said senior study author Dr. Douglas Levine. He is director of the division of gynecologic oncology at the Perlmutter Cancer Center, which is part of NYU Langone Health in New York City. For the study, Levine and his colleagues performed genetic analyses of ovarian cancer cells from 96 patients. Eggs from the ovaries travel through the fallopian tubes on their way to the uterus. The researchers discovered that ovarian cancer cells have more in common with cells covering the tips of fallopian tubes (tubal cells) than with those on the surface of ovaries. "We found no differences ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation

Obesity Linked to 13 Types of Cancer

Posted 3 Oct 2017 by Drugs.com

TUESDAY, Oct. 3, 2017 – There's a link between obesity and 40 percent of all the cancers diagnosed in the United States, health officials reported Tuesday. That doesn't mean too much weight is causing all these cancer cases, just that there's some kind of still-to-be explained association, according to the U.S. Centers for Disease Control and Prevention. Still, the study findings suggest that being obese or overweight was associated with cancer cases involving more than 630,000 Americans in 2014, and this includes 13 types of cancer. "That obesity and overweight are affecting cancers may be surprising to many Americans. The awareness of some cancers being associated with obesity and overweight is not yet widespread," Dr. Anne Schuchat, CDC deputy director, said during a midday media briefing. The 13 cancers include: brain cancer; multiple myeloma; cancer of the esophagus; ... Read more

Related support groups: Obesity, Weight Loss, Colorectal Cancer, Brain Tumor, Ovarian Cancer, Pancreatic Cancer, Stomach Cancer

FDA Approves Tablet Formulation of Lynparza (olaparib) for Maintenance Treatment of Ovarian Cancer

Posted 21 Aug 2017 by Drugs.com

August 17, 2017 – AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the U.S. and Canada) today announced that the US Food and Drug Administration (FDA) has granted approval for the PARP inhibitor, Lynparza (olaparib), as follows: New use of Lynparza tablets as a maintenance treatment of adult patients with recurrent, epithelial ovarian, fallopian tube or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy, regardless of BRCA status;1,2 New use of Lynparza tablets (2 tablets twice daily) as opposed to capsules (8 capsules twice daily);3 Lynparza tablets also now indicated (conversion from the current accelerated approval4) for the use in adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCA) advanced ovarian cancer, who have been treated with three or more prior lines of chemotherapy; patients ... Read more

Related support groups: Ovarian Cancer, Lynparza, Olaparib, Peritoneal Cancer, Fallopian Tube Cancer

Can a Blood Test Detect a Range of Cancers Earlier?

Posted 16 Aug 2017 by Drugs.com

WEDNESDAY, Aug. 16, 2017 – A new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late, a new study suggests. The test scans blood for DNA fragments released by cancerous tumors, explained lead researcher Dr. Victor Velculescu. By reviewing these DNA fragments for mutations found in 58 "cancer-driver" genes, the blood test detects many early stage cancers without rendering false positives for healthy people, said Velculescu, co-director of cancer biology at the Johns Hopkins Kimmel Cancer Center, in Baltimore. The test detected stage 1 or 2 colon, breast, lung or ovarian cancers between 59 percent and 71 percent of the time when assessing 200 patients previously diagnosed with cancer, researchers found. "If we are able to detect cancer earlier, our chances of saving lives would be much higher," Velculescu said. "The survival ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Diagnosis and Investigation

Treatment Costs Can Be Another Blow to Cancer Patients

Posted 27 Jul 2017 by Drugs.com

THURSDAY, July 27, 2017 – The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research reveals. "The current health law has greatly improved access to meaningful health coverage for cancer patients, survivors and all those with chronic diseases," Chris Hansen, president of the American Cancer Society Cancer Action Network, said in a network news release. "Yet costs remain a challenge for those facing cancer. Our country and our lawmakers should come together to find bipartisan solutions that begin to address patient costs without sacrificing the quality of coverage," he urged. Researchers surveyed financial navigators at 11 hospitals in nine states. Financial navigators – typically trained social workers or nurses – help cancer patients ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Prostate Cancer, Tamoxifen, Arimidex, Lupron Depot, Femara, Lung Cancer, Gleevec, Colorectal Cancer, Non-Small Cell Lung Cancer, Anastrozole, Brain Tumor, Letrozole, Skin Cancer, Tarceva

Many Terminal Cancer Patients Remain in Denial

Posted 20 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Pancreatic Cancer, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Medroxyprogesterone, Prostate Cancer, Tamoxifen, Fluorouracil, Arimidex, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Anastrozole, Votrient, Brain Tumor, Letrozole

Most Women Should Forgo Ovarian Cancer Screening: Panel

Posted 18 Jul 2017 by Drugs.com

TUESDAY, July 18, 2017 – The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft recommendation. "The task force found that screening women without signs or symptoms for ovarian cancer does not decrease the number of deaths from the disease, and may lead to unnecessary surgeries," Dr. Maureen Phipps said in a news release from the USPSTF. "Therefore, the task force recommends against screening for ovarian cancer in women who have no signs or symptoms, and who are not at high risk for ovarian cancer," she said. Phipps is a member of the task force, which is an independent, volunteer panel of national experts in prevention and evidence-based medicine. The new guidance reaffirms a 2012 final recommendation made by the USPSTF. Task force ... Read more

Related support groups: Ovarian Cancer, Diagnosis and Investigation, Body Imaging

When Is Risk Highest for Women With Breast Cancer Gene Mutations?

Posted 20 Jun 2017 by Drugs.com

TUESDAY, June 20, 2017 – For women who have genetic mutations that increase their risk of breast and ovarian cancers, researchers have better defined at what age those gene flaws are most likely to cause trouble. Knowing when gene-based cancer risks peak in a woman's life will help doctors and patients decide when to take drastic steps such as removing a breast or the ovaries to prevent cancer, said study senior author Antonis Antoniou. He's a researcher with the University of Cambridge's Department of Public Health and Primary Care in England. Breast cancer risk peaks around the 40s for BRCA1 mutation carriers and around the 50s for BRCA2 carriers, Antoniou said. "This gives women more guidance as to when it's safe to wait and when it's time to go ahead and do the surgery," said study co-author Dr. Mary Daly, founder and director of Fox Chase Cancer Center's Risk Assessment Program in ... Read more

Related support groups: Breast Cancer, Ovarian Cancer, Breast Cancer, Prevention, Diagnosis and Investigation

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

methotrexate, Avastin, Taxol, cisplatin, carboplatin, Cytoxan, cyclophosphamide, Zejula, Gemzar, view more... paclitaxel, gemcitabine, doxorubicin, Adriamycin, topotecan, etoposide, Platinol, Lynparza, Rubraca, Alkeran, Neosar, bevacizumab, Hycamtin, olaparib, thiotepa, melphalan, Hexalen, Cytoxan Lyophilized, dactinomycin, Tepadina, doxorubicin liposomal, Adriamycin PFS, Thioplex, Adriamycin RDF, Platinol-AQ, Carboplatin Novaplus, Ethyol, Doxil, Paraplatin, Onxol, Toposar, Etopophos, VePesid, rucaparib, Cosmegen, amifostine, niraparib, altretamine